MERCAPTAMINE (Cystadrops®)
Clinical Indication
Corneal cystine crystal deposits in patients aged ≥ two years with cystinosis
Comments
New formulation
Not yet reviewed
Date of classification
June 2017
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.